Xact Robotics has received approval to add robotic-assisted ablation to the interventional radiology procedures for which the Ace system brand previously received FDA’s OK.
Xact says Ace has been used clinically in more than 200 other types of CT-guided percutaneous procedures.
The company says the approval for ablations will enable interventional radiologists to perform these surgeries with nonlinear control that enables high accuracy and average skin-to-target times of less than nine minutes.
“Ablation procedures present a challenge for many users in terms of accuracy and time required to place the ablation probes,” said Harel Gadot, the founder and executive chairman of Xact, in an announcement May 18. “The proven ability of our system to reach relatively small targets, regardless of target movement or obstacles, with unparalleled accuracy and one insertion into target, will deliver better patient outcomes with greater efficiency.”
Privately-owned Xact Robotics has offices in Hingham, Massachusetts, and Caesarea, Israel.